Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/2155309

Download in:

View as

General Info

PMID
2155309